VTGN
Vistagen Therapeutics Inc.
Company Overview
| Mkt Cap | $124.26M | Price | $3.94 |
| Volume | 231.63K | Change | +5.07% |
| P/E Ratio | -2.4 | Open | $3.77 |
| Revenue | $486.0K | Prev Close | $3.75 |
| Net Income | $-51.4M | 52W Range | $1.90 - $4.52 |
| Div Yield | N/A | Target | $13.00 |
| Overall | 55 | Value | 60 |
| Quality | -- | Technical | 50 |
No chart data available
Stock Overview
Updated DailyVistagen Therapeutics Inc. (VTGN) is a leading Healthcare company in the Biotechnology industry, currently trading at $3.94 with a market capitalization of $124.26 million. The stock is positioned in the upper portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows VTGN with a volume of 232K shares. The stock opened up 0.53% from yesterday's close of $3.75. Current analyst estimates project earnings of $-1.56 per share for this year, with next year targeting $-1.71.
VTGN demonstrates neutral technical outlook based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for VTGN include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 229.9%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 12:30 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VTGN | $3.94 | +5.1% | 231.63K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Vistagen Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW